Evidence map›Paper›PMID 40992899›Full record

ArticleBMJ (Clinical research ed.)2025

First mammography screening participation and breast cancer incidence and mortality in the subsequent 25 years: population based cohort study.

Ziyan Ma, Wei He, Yuqi Zhang, Xinhe Mao, José Tapia, Per Hall, Keith Humphreys, Kamila Czene

Expression of concernAbstract read
In one paragraph

Article in BMJ (Clinical research ed.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It carries an expression of concern. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Ziyan MaDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Wei HeDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden zjuhewei@zju.edu.cn.ORCID 0000-0003-0161-3274
Yuqi ZhangDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Xinhe MaoDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
José TapiaDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Per HallDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Keith HumphreysDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Kamila CzeneDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo determine whether women who did not attend their first mammography screening invitation have a long term risk of poor screening adherence and breast cancer outcomes.

designPopulation based cohort study.

settingStockholm, Sweden.

participants432 775 women who received invitations to the Swedish Mammography Screening Programme between 1991 and 2020 and were initially invited at either 50 years of age or 40 years of age.

main outcome measuresScreening adherence, breast cancer incidence, tumour characteristics, and breast cancer mortality tracked through linkage to multiple Swedish national registers, with follow-up until 2023 (up to 25 year follow-up period). Cumulative breast cancer incidences were calculated from first screening participation. Cox proportional hazards models estimated hazard ratios for breast cancer mortality; logistic regression models assessed associations with tumour characteristics by odds ratios.

resultsDuring a total of 4 940 375 person years of follow-up, 16 059 new cases of breast cancer were documented. Among women invited to their first mammography screening, 32.1% (n=138 760) did not participate. These non-participants were persistently less likely to attend subsequent screenings and were more likely have symptom detected, advanced stage breast cancer diagnosed. Specifically, compared with first screening participants, non-participants had an odds ratio of 1.53 (95% confidence interval 1.24 to 1.88) for stage III cancer (160 (4.1%)

conclusionsThis study shows that first screening non-participants represent a large population at long term risk of dying from breast cancer, providing an opportunity for targeted interventions to improve adherence to screening and thereby decrease mortality risk.

Indexed as

Breast NeoplasmsEarly Detection of CancerMammographyMass ScreeningPatient ComplianceAdultAgedCohort StudiesFemaleHumansIncidenceMiddle AgedSweden

Identifiers

PMID40992899
PMCPMC12459011

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.